Literature DB >> 31617736

Clinical research assessment by flow cytometry of biomarkers for infectious stratification in an Emergency Department.

Pénélope Bourgoin1,2, Thomas Soliveres3, Dalia Ahriz3, Isabelle Arnoux4, Christian Meisel5,6, Nadine Unterwalder6, Pierre-Emmanuel Morange2,4, Pierre Michelet3, Fabrice Malergue1, Thibaut Markarian3.   

Abstract

Aim: Management of patients with infections within the Emergency Department (ED) is challenging for practitioners, as the identification of infectious causes remains difficult with current techniques. A new combination of two biomarkers was tested with a new rapid flow cytometry technique. Materials & methods: Subjects from the ED were tested for their CD64 on neutrophils (nCD64) and CD169 on monocytes (mCD169) levels and results were compared to their clinical records.
Results: Among 139 patients, 29% had confirmed bacterial infections and 5% viral infections. nCD64 and mCD169 respectively showed 88 and 86% sensitivity and 90 and 100% specificity for identifying subjects in bacterial or viral conditions.
Conclusion: This point-of-care technique could allow better management of patients in the ED.

Entities:  

Keywords:  CD169; CD64; bacterial infections; emergency department; flow cytometry; viral infections

Mesh:

Substances:

Year:  2019        PMID: 31617736     DOI: 10.2217/bmm-2019-0214

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  6 in total

1.  One-step White Blood Cell Extracellular Staining Method for Flow Cytometry.

Authors:  Ines Ait Belkacem; Pénélope Bourgoin; Jean Marc Busnel; Franck Galland; Fabrice Malergue
Journal:  Bio Protoc       Date:  2021-08-20

2.  Role of the interferons in CD64 and CD169 expressions in whole blood: Relevance in the balance between viral- or bacterial-oriented immune responses.

Authors:  Pénélope Bourgoin; Géraldine Biéchelé; Inès Ait Belkacem; Pierre-Emmanuel Morange; Fabrice Malergue
Journal:  Immun Inflamm Dis       Date:  2020-02-07

3.  Monocyte CD169 expression in COVID-19 patients upon intensive care unit admission.

Authors:  Marine Ortillon; Remy Coudereau; Martin Cour; Thomas Rimmelé; Marine Godignon; Morgane Gossez; Hodane Yonis; Laurent Argaud; Anne-Claire Lukaszewicz; Fabienne Venet; Guillaume Monneret
Journal:  Cytometry A       Date:  2021-02-05       Impact factor: 4.714

4.  Validation of a Quick Flow Cytometry-Based Assay for Acute Infection Based on CD64 and CD169 Expression. New Tools for Early Diagnosis in COVID-19 Pandemic.

Authors:  Alejandra Comins-Boo; Maria Gutiérrez-Larrañaga; Adriel Roa-Bautista; Sandra Guiral Foz; Mónica Renuncio García; Elena González López; Juan Irure Ventura; María Carmen Fariñas-Álvarez; David San Segundo; Marcos López Hoyos
Journal:  Front Med (Lausanne)       Date:  2021-03-23

5.  A rapid, easy, and scalable whole blood monocyte CD169 assay for outpatient screening during SARS-CoV-2 outbreak, and potentially other emerging disease outbreaks.

Authors:  Moïse Michel; Fabrice Malergue; Inès Ait Belkacem; Pénélope Bourgoin; Pierre-Emmanuel Morange; Isabelle Arnoux; Tewfik Miloud; Matthieu Million; Hervé Tissot-Dupont; Jean-Louis Mege; Joana Vitte; Jean-Marc Busnel
Journal:  SAGE Open Med       Date:  2022-08-03

Review 6.  Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease.

Authors:  Silva Herzog; Paraskevi C Fragkou; Borros M Arneth; Samr Mkhlof; Chrysanthi Skevaki
Journal:  Front Med (Lausanne)       Date:  2022-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.